Given the opposite prognostic value of PDL1 expression in pancreatic cancer (unfavorable value) when compared with breast cancer and GIST (favorable value) [23, 25], we compared the biological and immune features associated with PDL1 expression in these cancers. This evidence concerns the gene CD274 and familial pancreatic carcinoma.